This is a rare type of leukemia. It's a slow-growing cancer of the blood. The leukemia cells are mostly neutrophils, which are a type of white blood cell. It's called 'chronic' because it usually develops slowly over time.
Every report comes from a Lived member, sent anonymously.
Have you tried Hydroxyurea for Chronic Neutrophilic Leukemia?
Chronic neutrophilic leukemia (CNL) is a rare blood cancer in which the bone marrow keeps making too many neutrophils, the white blood cells that normally fight bacterial infection. Unlike acute leukemias, the extra cells are mostly mature and working neutrophils, so the disease often develops quietly. Many people feel well and learn they have it only because a routine blood count shows a very high white cell count. Others notice tiredness, bone pain, itching, easy bruising or gout, or a sense of fullness under the left ribs because the spleen has enlarged. CNL belongs to a family of marrow disorders called myeloproliferative neoplasms, which also includes polycythemia vera and myelofibrosis. It is very uncommon, estimated at about one case per 10 million people each year, and is usually diagnosed around age 70. Although the word chronic suggests a slow course, CNL is often more aggressive than its name implies, which is why an accurate diagnosis matters.
CNL develops when blood-forming cells in the marrow pick up genetic changes during a person's lifetime. In most people the key change is in a gene called CSF3R, which carries instructions for the receptor that tells the marrow to make neutrophils. When this receptor is altered, it stays switched on and drives neutrophil production without the usual signals. Other acquired changes, especially in a gene called ASXL1, often appear alongside it and can affect how the disease behaves. These are not inherited changes in almost all cases, and CNL is not caused by anything a person did. No lifestyle factor or environmental exposure has been clearly shown to cause it. A single family passing a CSF3R change through several generations has been reported, but that is a rare exception.
A high white cell count is common and is far more often caused by infection, inflammation or medicines such as corticosteroids (steroid anti-inflammatory drugs) than by leukemia. So the first step is to look for and rule out those everyday explanations. Some plasma cell disorders, such as myeloma, can also raise neutrophils and need to be excluded. When a high count persists without a clear reason, a blood specialist (hematologist) examines the blood under a microscope and usually performs a bone marrow biopsy, in which a small sample is taken from the hipbone with a needle after the skin is numbed. A normal white count is about 4,500 to 11,000 cells per microliter of blood. CNL is typically diagnosed when the count stays at 25,000 or higher (some criteria accept 13,000 or higher when a CSF3R change is found), when at least 80% of those cells are neutrophils, and when very few immature cells are present. Genetic tests on the blood or marrow look for a CSF3R change, which strongly supports the diagnosis, and confirm the absence of the BCR::ABL1 gene fusion (the Philadelphia chromosome) that defines a different disease, chronic myeloid leukemia. The specialist also checks that the picture does not better fit a related condition called atypical chronic myeloid leukemia, in which the neutrophils look abnormal.
There is no single standard treatment for CNL, largely because it is so rare that few clinical trials exist. Care is guided by symptoms, blood counts, spleen size and how high-risk the disease appears, which doctors estimate from the platelet count, the white count and whether an ASXL1 change is present. An allogeneic stem cell transplant, which replaces the person's blood-forming system with cells from a donor, is the only treatment that may cure CNL. It is most often considered for people who are fit enough, have a suitable donor and have higher-risk disease. Outcomes appear better when it is done while the disease is still in its chronic phase. The trade-off is substantial: transplant carries serious risks, including graft-versus-host disease (donor immune cells attacking the body), graft failure and death from complications, and recovery takes months. For people who are not transplant candidates, or while preparing for one, medicines aim to bring down the white count, shrink the spleen and ease symptoms. Hydroxyurea, an oral chemotherapy pill, is commonly used first; it often works, but the effect tends to fade after about a year. Ruxolitinib (Jakafi), a Janus kinase (JAK) inhibitor that blocks the signaling pathway a CSF3R change switches on, is used off-label. In a small trial about a third of patients had their counts improve, mostly those with CNL or a specific CSF3R change, while people without a CSF3R change rarely responded. Lower red cell and platelet counts were its most common significant side effects. Interferon alfa, an immune-signaling medicine, has helped some people in individual reports. None of these medicines has been shown to change the long-term course, and clinical trials are an important option to ask about.
CNL varies a great deal from person to person. Some people stay stable for years with periodic blood tests and pills, while others progress within months. Over time the disease can transform into acute leukemia, a fast-growing form that is much harder to treat; this happens in roughly 10% to 25% of people. Bleeding problems are another known complication, sometimes even when platelet counts look normal, and an enlarged spleen can cause discomfort under the left ribs. On average the outlook is serious. Published studies, which are small, report median survival of roughly 15 to 31 months, though some people live much longer and individual prognosis depends on risk factors and whether a transplant is possible. Day to day, living with CNL usually means regular visits with a hematologist and frequent blood counts to adjust medication and watch for signs of progression. Because decisions about transplant work best when made early, many people are referred to a center with experience in rare myeloproliferative neoplasms soon after diagnosis.
Follow up with a clinician if a blood test shows a white count that stays high without an obvious cause such as infection, and ask about referral to a hematologist. If you have CNL, contact your care team promptly about new or unusual bruising, nosebleeds or bleeding gums, growing pain or fullness under the left ribs, or worsening tiredness or bone pain, since these can signal a bleeding problem or changing disease. Bleeding that is heavy or will not stop, or vomiting blood, needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chronic Neutrophilic Leukemia is like, what's helped you, or ask the community a question.